Investing.com - Gilead (NASDAQ: GILD) reported first quarter EPS of $-3.34, $4.90 worse than the analyst estimate of $1.56. Revenue for the quarter came in at $6.65B versus the consensus estimate of $6.36B.
Guidance
Gilead sees FY 2024 EPS of $3.45-$3.85 versus the analyst consensus of $3.67.
Gilead's stock price closed at $65.27. It is down -17.92% in the last 3 months and down -22.06% in the last 12 months.
Gilead saw 0 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See Gilead's stock price’s past reactions to earnings here.
According to InvestingPro, Gilead's Financial Health score is "great performance".
Check out Gilead's recent earnings performance, and Gilead's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar